Glazer Capital LLC’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Glazer Capital LLC’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-35,381	Closed	-$7.63M	–	396
2020 Q3	$7.63M	Buy	35,381 +23,560	+199%	+$5.08M	0.37%	80
2020 Q2	$2.54M	Sell	11,821 -8,506	-42%	-$1.81M	0.18%	88
2020 Q1	$4.27M	Buy	20,327 +15,327	+307%	+$3.21M	0.28%	75
2019 Q4	$1.05M	Buy	+5,000	New	+$1.04M	0.13%	87
2019 Q1	–	Sell	-2,500	Closed	-$491K	–	156
2018 Q4	$491K	Buy	+2,500	New	+$490K	0.07%	99

Other funds holding RVPH

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Glazer Capital LLC's RVPH Position: Q4 2020 in Review

Glazer Capital LLC sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2020, closing a stake of 35,381 shares — an estimated $7.63M sold.

Glazer Capital LLC first reported a position in RVPH in Q4 2018 and held it in 5 quarters. The position peaked at $7.63M in Q3 2020. 3 funds tracked by Wall St. Rank hold RVPH as of Q4 2020.

Glazer Capital LLC reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2020 after selling out during the quarter.
Glazer Capital LLC sold 35,381 REVIVA PHARMA HLDGS INC shares in Q4 2020, an estimated $7.63M.
Glazer Capital LLC first reported a position in REVIVA PHARMA HLDGS INC in Q4 2018 and held it in 5 quarters.
Glazer Capital LLC's REVIVA PHARMA HLDGS INC position peaked at $7.63M in Q3 2020.
3 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2020.

Based on Glazer Capital LLC's 13F filing for Q4 2020, filed 16 Feb 2021.